Author: Mark Salvia

Nasdaq Delists Intellipharmaceutics, Aceto, GTY Technology’s Warrant

Nasdaq (NDAQ) on late Friday said it will delist two medical companies, namely Intellipharmaceutics International (IPCI) and Aceto (ACET), as well as the warrant of GTY Technology Holdings (GTYHW). According to a statement, Intellipharmaceutics International’s stock was suspended on March 21 and has not traded on Nasdaq since that time, and Aceto’s stock was suspended on April 3 and has […]